Opentrons Robotics Launches New Workstations to Support Genomics and Proteomics Applications
Retrieved on:
Thursday, March 10, 2022
Technology, Research, Genetics, Other Technology, Biotechnology, Health, Pharmaceutical, Other Science, Science, Industry, Genomics, NGS, RNA transfection, PCR, COVID-19 testing, Automation, Research, Workflow, Molecular biology, Magnetism, Pyrosequencing, Robotics, PRL, Solution, COVID-19, Drug discovery, Opentrons, Proteomics, Fine chemical, Vaccine, Opentrons Labworks, Inc., Opentrons Robotics, OPENTRONS LABWORKS, INC., OPENTRONS ROBOTICS
The expansion of our OT-2 portfolio will bring the benefits of radically simple, accessible automation to new customers, said David Kim, general manager of Opentrons Robotics.
Key Points:
- The expansion of our OT-2 portfolio will bring the benefits of radically simple, accessible automation to new customers, said David Kim, general manager of Opentrons Robotics.
- Opentrons new workstations will bring all these benefits to scientists working across genomics and proteomics applications.
- Through our business unit, Opentrons Robotics, thousands of institutions are automating R&D operations with flexible, easy-to-use lab robots.
- Opentrons Robotics, a business unit of Opentrons Labworks, Inc., is the industry leader in flexible, user-friendly automation for life science R&D labs.